New Treatments for POTS: Emerging Therapies and Research
Do you ever feel like your POTS symptoms are running your life, no matter how hard you try to manage them? What if there were new treatments for POTS that could really make a difference?
From cutting-edge medications and innovative non-drug therapies to high-tech gadgets that monitor your health, advanced treatments for POTS are evolving at a rapid pace. These aren’t just future possibilities. They’re happening right now.
Key Takeaways
- New Treatments for POTS Are Emerging: Medications such as ivabradine, droxidopa, and low-dose naltrexone are showing promise for improving symptoms and quality of life in some patients with POTS.
- Innovative Therapies Expand Treatment Options: Non-pharmacological approaches including vagus nerve stimulation (VNS), biofeedback, wearable technology, and personalized treatment strategies are creating new opportunities for symptom management.
- Research Continues to Advance POTS Care: Ongoing studies into autoimmune therapies, gut microbiome interventions, and individualized treatment plans may help shape the future of POTS treatment.
Curious about what’s out there for POTS treatments? Let’s find out!
- What Are the New Treatments for POTS?
- The Evolution of POTS Treatments
- Current Standard Treatments for POTS
- New Medications for POTS
- Latest Research on New Treatments for POTS
- Innovative Non-Pharmacological Therapies
- The Role of Technology in POTS Treatment
- Surgical Options: Are They Viable?
- New Treatments for POTS at a Glance
- Future Directions in POTS Research
- Take Control of Your Health with the Latest POTS Treatments
What Are the New Treatments for POTS?
New treatments for POTS include emerging medications such as ivabradine, droxidopa, and low-dose naltrexone, as well as innovative therapies like vagus nerve stimulation (VNS), biofeedback, and wearable health technology.¹
Researchers are also exploring autoimmune therapies, gut microbiome interventions, and personalized treatment approaches that may improve symptom management and quality of life for people living with POTS.
For more information on POTS, learn about how it affects the Autonomic Nervous System.
The Evolution of POTS Treatments
POTS treatment has come a long way since the syndrome was first described in the 1990s. At first, managing the condition focused primarily on increasing blood volume and improving blood flow to the brain.
Early Treatments
Early approaches often involved a combination of increased fluid and salt intake, compression garments, and medications like fludrocortisone and midodrine.¹ Want to know more about these standard treatments? Check out our comprehensive guide, Effective Treatments for POTS.²
A More Personalized Approach
As our understanding of POTS has grown, so has our approach to treatment. We've seen a shift from a one-size-fits-all strategy to more personalized treatment plans that address the unique underlying causes and symptoms of each patient.
Embracing Innovation
This evolution has opened the door to some pretty exciting advanced and innovative solutions, which we'll explore in this guide. By tailoring treatments to individual needs, we're better equipped to help POTS patients manage their symptoms and get back to living their best lives.
Current Standard Treatments for POTS
Before we get into the cutting-edge treatments, let’s review the current standard approaches to managing POTS.
Lifestyle Modifications
First up, we’ve got some simple but effective changes you can make to your daily life. This typically involves:
- Increasing fluid intake to 8–12 cups per day
- Boosting salt consumption to ½ to 2 teaspoons daily
This helps increase blood volume, which can alleviate symptoms like dizziness and fatigue.¹
Compression Garments
These tight-fitting clothes, like compression socks or full-body suits, help improve blood flow and reduce dizziness and lightheadedness when you stand up.¹
Regular Exercises
Exercising regularly is important for POTS management, but it's not as simple as hitting the gym. Your doctor might recommend starting with exercises you can do lying down or reclining, such as swimming, using a recumbent bike, or rowing.
As you get stronger, you may be able to add more upright exercises like gentle walking as tolerated.³
Medications
There are several medications that can help manage POTS symptoms, including:
- Beta-blockers like propranolol can help slow down the rapid heart rate associated with POTS.
- Fludrocortisone helps your body hold onto more salt and water.
- Midodrine can help improve blood pressure upon standing.⁴
Physical Therapy
Having a physical therapist who understands POTS can be a big help. They can design a specialized exercise program that starts off easy and gradually builds your strength and stamina.
Explore more exercise and physical therapy options for managing POTS.
Dietary Changes
What you eat can make a big difference with POTS. Increasing salt intake, eating smaller meals, and staying hydrated are all important components of symptom management.
Products like Buoy may help support hydration and electrolyte balance as part of a broader treatment strategy.
Learn more in our POTS diet and nutrition guide.
Increasing salt intake, such as adding high-quality salt to your meals, is a common dietary change that can help manage POTS symptoms.
Exploring Advanced Pharmacological Treatments
In recent years, we’ve seen some exciting developments in POTS medications, giving us more ways to tackle this challenging condition.
Ivabradine
Originally used for heart conditions, ivabradine has shown promise in managing POTS symptoms. A study found that ivabradine significantly reduced heart rate and improved quality of life for POTS patients.⁵
Droxidopa
This medication is being studied for its potential to improve standing tolerance and reduce fatigue.⁶
Pyridostigmine
Recent studies have shown pyridostigmine to be effective in managing POTS symptoms, particularly in patients with autoimmune-related POTS.⁴
Low-Dose Naltrexone
Traditionally used to treat opioid addiction, low-dose naltrexone is being explored for its anti-inflammatory and pain-reducing effects in POTS patients.⁷
New Medications for POTS
Additional therapies currently being investigated include:
- Modafinil
- Octreotide
- Desmopressin
These emerging treatments represent the ongoing effort to improve outcomes for people living with POTS.
Latest Research on New Treatments for POTS
Researchers continue to explore new treatment options for POTS, with several recent developments showing promise.
Ivabradine Research
A 2025 study from researchers at Virginia Commonwealth University found that ivabradine reduced standing heart rate and improved symptoms such as fatigue, chest pain, dizziness, and lightheadedness in patients with POTS.¹⁹ Researchers also suggested that elevated heart rate may play a larger role in the condition than previously understood.
Noninvasive Vagus Nerve Stimulation
Clinical trial data presented by the Heart Rhythm Society found that low-level transcutaneous vagus nerve stimulation significantly reduced postural tachycardia compared to placebo treatment. Researchers believe this non-pharmacological therapy may become an important option for patients who do not respond to traditional treatments.
Personalized Treatment Approaches
Emerging research is increasingly focused on identifying the underlying causes of POTS in individual patients, helping clinicians create more personalized treatment plans based on symptom patterns, autoimmune involvement, and nervous system dysfunction.
Innovative Non-Pharmacological Therapies
Beyond medications, several innovative management techniques are showing promise.
Vagus Nerve Stimulation (VNS)
VNS works by sending mild electrical impulses to the vagus nerve in an effort to stabilize the autonomic nervous system.⁹
Biofeedback and Neurofeedback
These approaches help patients learn to regulate physiological responses such as heart rate and blood pressure.¹⁰ Discover how to manage blood pressure fluctuations while dealing with POTS symptoms.
Autonomic Reconditioning Therapy
This specialized therapy gradually retrains the autonomic nervous system through a structured exercise progression.
Transcutaneous Electrical Nerve Stimulation (TENS)
TENS may help improve blood flow, reduce pain, and potentially assist autonomic regulation.¹¹
Electrical stimulation therapy, such as TENS, can help alleviate pain and improve muscle function, offering potential benefits for managing POTS symptoms.
The Role of Technology in POTS Treatment
Technology is revolutionizing the way we treat POTS.
Wearable Devices
Smartwatches and wearables can continuously monitor heart rate, blood pressure, and posture.
Telemedicine
Remote consultations improve access to specialists.
Virtual Reality (VR)
Some clinics are exploring VR-assisted rehabilitation programs.
AI-Powered Diagnostics
Artificial intelligence is helping clinicians identify symptom patterns more efficiently.
Smart Hydration Tracking
Hydration tracking tools can help patients better manage one of the most important aspects of POTS care.
Surgical Options: Are They Viable?
While surgery is rarely a first-line treatment, some interventions are being explored in severe cases.
Cardiac Ablation
May be considered for patients with specific arrhythmias.¹²
Celiac Plexus Block
Can provide symptom relief for certain gastrointestinal complications.¹³
Artificial Pacemaker Implantation
May be considered in rare cases involving significant bradycardia or asystole.¹⁴
New Treatments for POTS at a Glance
Take a look at new treatments for POTS, including the type and current standing.
| Treatment | Type | Current Status |
| Ivabradine | Medication | Showing promising results for reducing heart rate and improving symptoms |
| Droxidopa | Medication | Being studied for standing tolerance and fatigue |
| Low-Dose Naltrexone | Medication | Early evidence suggests symptom improvement in some patients |
| Vagus Nerve Stimulation | Non-drug therapy | Clinical trials show promising results |
| Biofeedback | Behavioral therapy | Used to help regulate physiological responses |
| Wearable Technology | Monitoring tool | Increasingly used for symptom tracking and management |
Learn more about supportive therapies and treatments for POTS.
Future Directions in POTS Research
The future of POTS treatment looks promising.
Autoimmune Therapies
Researchers are investigating therapies that target autoimmune mechanisms linked to POTS.¹⁶
Gut Microbiome Interventions
Studies are exploring how gut health may influence symptom severity.¹⁷
Gene Therapy
Future therapies may address genetic contributors to POTS.
Stem Cell Therapy
Early-stage research is evaluating whether stem cells may help repair damaged autonomic nerves.¹⁸
Personalized Medicine
Advances in diagnostics may allow treatments to be tailored more precisely to individual patients.
Take Control of Your Health with the Latest POTS Treatments
As we've explored, POTS treatments are evolving rapidly, offering new hope for those living with this challenging condition.
Consult with a POTS Professional
Always consult your healthcare provider before trying new therapies. They can help determine which options may be appropriate for your specific situation.
Finding the Right Combination of Treatments
Managing POTS often involves finding the right combination of treatments, lifestyle strategies, and hydration support.
Products like Buoy's Rescue Drops contain 6x the amount of sodium compared to other electrolytes, making them a perfect supplement for alleviating POTS symptoms.
As researchers continue to develop new treatments for POTS, emerging therapies such as ivabradine, vagus nerve stimulation, and personalized medicine approaches may offer additional options beyond traditional symptom management strategies.
Learn More About Managing POTS
Ready to learn more? Explore our comprehensive guides covering hydration, symptom management, and the latest research.
You're Not Alone in This Journey
Millions of people are living with POTS, and ongoing research continues to improve understanding and treatment options.
The Future of POTS Management Is Bright
As research advances and new therapies emerge, there is more reason than ever to feel hopeful about the future of POTS care.
References:
- Apilado, K., Franzos, M. A., Allard, R., Mancuso, J. D., Tribble, D., Saunders, D., & Koehlmoos, T. P. (2025). Oral medications for the treatment of postural orthostatic tachycardia syndrome: A systematic review of studies before and during the COVID-19 pandemic. Frontiers in Neurology, 15, 1515486. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11775448/
- Dysautonomia International. (n.d.). Lifestyle Adaptations for POTS. Retrieved from https://www.dysautonomiainternational.org/page.php?ID=44
- Dysautonomia International. (n.d.). Exercises of Dysautonomia Patients. Retrieved from https://www.dysautonomiainternational.org/page.php?ID=43
- Abed, H., Ball, P. A., & Wang, L. X. (2012). Diagnosis and Management of Postural Orthostatic Tachycardia Syndrome: A Brief Review. Journal of Geriatric Cardiology : JGC, 9(1), 61–67. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390096/
Bavry, A. A. (2021). Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural - Orthostatic Tachycardia Syndrome – Ivabradine in POTS. Journal of the American College of Cardiology. Retrieved from https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2021/02/16/19/13/Ivabradine-in-POTS#
- Ruzieh, M., Dasa, O., Pacenta, A., Karabin, B. & Grubb, B. (2017). Droxidopa in the Treatment of Postural Orthostatic Tachycardia Syndrome. American Journal of Therapeutics, 24(2), e157–e161. Retrieved from https://doi.org/10.1097/MJT.0000000000000468
- Stallkamp Tidd, S. J., Cantrell, C., Greene, B. D. & Wilson, R. (2023). Low-Dose Naltrexone Use in Postural Orthostatic Tachycardia Syndrome: A Case Series. Cureus, 15(8), e43426. Retrieved from https://doi.org/10.7759/cureus.43426
- Coffin, S. T., Black, B. K., Biaggioni, I., Paranjape, S. Y., Orozco, C., Black, P. W., Dupont, W. D., Robertson, D. & Raj, S. R. (2012). Desmopressin Acutely Decreases Tachycardia and Improves Symptoms in the Postural Tachycardia Syndrome. Heart Rhythm, 9(9), 1484–1490. Retrieved from https://doi.org/10.1016/j.hrthm.2012.05.002
- Chakraborty, P., Farhat, K., Morris, L., Whyte, S., Yu, X. & Stavrakis, S. (2023). Non-Invasive Vagus Nerve Stimulation in Postural Orthostatic Tachycardia Syndrome. Arrhythmia & Electrophysiology Review, 12, e31. Retrieved from https://doi.org/10.15420/aer.2023.20
- Lehrer, P. M., Vaschillo, E., & Vaschillo, B. (2000). Resonant frequency biofeedback training to increase cardiac variability: Rationale and manual for training. Applied Psychophysiology and Biofeedback, 25(3), 177–191. Retrieved from https://link.springer.com/article/10.1023/A:1009554825745
- Johnson, M. I., Paley, C. A., Jones, G., Mulvey, M. R., & Wittkopf, P. G. (2022). Efficacy and safety of transcutaneous electrical nerve stimulation (TENS) for acute and chronic pain in adults: A systematic review and meta-analysis of 381 studies. BMJ Open, 12(2), e051073. Retrieved from https://bmjopen.bmj.com/content/12/2/e051073
- Calkins, H., Hindricks, G., Cappato, R., Kim, Y. H., Saad, E. B., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, J., et al. (2018). 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm, 15(10), e275–e444. Retrieved from https://www.heartrhythmjournal.com/article/S1547-5271(17)31041-5/fulltext
- de Oliveira, R., dos Reis, M. P., Prado, W. A. (2004). The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain. Pain, 110(1–2), 400–408. Retrieved from https://pubmed.ncbi.nlm.nih.gov/15275787/
- Kanjwal, K., Kichloo, A., Qadir, R. & Grubb, B. P. (2021). Further Observations on the Use of Pacemakers in Patients with Postural Orthostatic Tachycardia Syndrome with Demonstrated Asystole. The Journal of Innovations in Cardiac Rhythm Management, 12(3), 4447–4450. Retrieve from https://doi.org/10.19102/icrm.2021.120307
- Li, H., Yu, X., Liles, C., Khan, M., Vanderlinde-Wood, M., Galloway, A., Zillner, C., Benbrook, A., Reim, S., Collier, D., Hill, M.A., Raj, S.R., Okamoto, L.E., Cunningham, M.W., Aston, C.E. & Kem, D.C. (2014). Autoimmune Basis for Postural Tachycardia Syndrome. Journal of the American Heart Association, 3(1):e000755. doi: 10.1161/JAHA.113.000755. Retrieved from https://pubmed.ncbi.nlm.nih.gov/24572257/
- Cleveland Clinic. (2023). Autoimmunity and Postural Orthostatic Tachycardia Syndrome: Implications in Diagnosis and Management. Retrieved from https://consultqd.clevelandclinic.org/autoimmunity-and-postural-orthostatic-tachycardia-syndrome-implications-in-diagnosis-and-management
- Ishimwe, J. A., Breier, N., Saleem, M., Kastner, P. D., Kirabo, A., & Shibao, C. A. (2022). The Gut Microbiota and Short-Chain Fatty Acids Profile in Postural Orthostatic Tachycardia Syndrome. Frontiers in Physiology, 13, 879012. Retrieved from https://doi.org/10.3389/fphys.2022.879012
- Numan, M. T., Kamdar, A., Young, J. & Butler, I. J. (2017). Autologous Adipose Stem Cell Therapy for Autonomic Nervous System Dysfunction in Two Young Patients. Stem Cells and Development, 26(6), 391–393. Retrieve from https://doi.org/10.1089/scd.2016.0196
- Trani, O. (2025). Heart failure drug ivabradine shows promise for treating POTS symptoms, new study finds. VCU Health. Retrieved from https://www.vcuhealth.org/news/heart-failure-drug-ivabradine-shows-promise-for-treating-pots-symptoms-new-study-finds/